It stimulates collagen synthesis (up to 70% increase), promotes blood vessel growth, and accelerates wound healing
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial Summary: This Phase 1b trial assessed the safety, tolerability, pharmacokinetics, and pharmacodynamics of co-administering once-weekly subcutaneous cagrilintide (at various doses) with semaglutide 2.4 mg in participants for weight management
The affinity of the GHK tripeptide for copper is exceptionally high, and it is this complex that is believed to be the primary biologically active form
May cause gastrointestinal discomfort
Animal carcasses were collected 72 h after administration